Status:
COMPLETED
Valsartan/Hydrochlorothiazide Combination vs Amlodipine in Patients With Hypertension, Diabetes, and Albuminuria.
Lead Sponsor:
Novartis
Conditions:
Hypertension
Eligibility:
All Genders
40-80 years
Phase:
PHASE4
Brief Summary
The purpose of this study is assess if treatment with valsartan and a diuretic, hydrochlorothiazide, has beneficial effects in people with high blood pressure, diabetes, and albuminuria (protein in th...
Eligibility Criteria
Inclusion
- type 2 diabetes
- elevated blood pressure and pulse pressure
- albuminuria
Exclusion
- Severe hypertension
- History of stroke, myocardial infarction, heart failure, chest pain, abnormal heart rhythm
- Liver, kidney (not caused by diabetes), or pancreas disease
- Type 1 diabetes or uncontrolled type 2 diabetes
- Allergy to certain medications used to treat high blood pressure
- Other protocol-defined inclusion/exclusion criteria may apply.
Key Trial Info
Start Date :
March 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2006
Estimated Enrollment :
144 Patients enrolled
Trial Details
Trial ID
NCT00171561
Start Date
March 1 2003
End Date
September 1 2006
Last Update
November 8 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Novartis Pharmaceuticals
Basel, Switzerland